Aristotle Capital Boston LLC Has $21.02 Million Holdings in Novanta Inc. $NOVT

Aristotle Capital Boston LLC increased its stake in shares of Novanta Inc. (NASDAQ:NOVT) by 18.7% in the fourth quarter, Holdings Channel reports. The firm owned 176,676 shares of the technology company’s stock after buying an additional 27,791 shares during the quarter. Novanta accounts for approximately 1.2% of Aristotle Capital Boston LLC’s holdings, making the stock its 28th biggest holding. Aristotle Capital Boston LLC’s holdings in Novanta were worth $21,023,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Assetmark Inc. grew its stake in Novanta by 22.4% in the fourth quarter. Assetmark Inc. now owns 541 shares of the technology company’s stock valued at $64,000 after acquiring an additional 99 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Novanta by 120.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock worth $51,000 after acquiring an additional 233 shares in the last quarter. Van ECK Associates Corp increased its holdings in shares of Novanta by 17.2% in the third quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock worth $163,000 after acquiring an additional 239 shares in the last quarter. Amundi increased its holdings in shares of Novanta by 1.4% in the third quarter. Amundi now owns 18,287 shares of the technology company’s stock worth $1,908,000 after acquiring an additional 245 shares in the last quarter. Finally, Nicolet Advisory Services LLC increased its holdings in shares of Novanta by 7.1% in the third quarter. Nicolet Advisory Services LLC now owns 4,046 shares of the technology company’s stock worth $409,000 after acquiring an additional 269 shares in the last quarter. 98.35% of the stock is owned by institutional investors and hedge funds.

Novanta Stock Down 2.4%

NOVT stock opened at $151.43 on Thursday. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. The stock has a market capitalization of $5.39 billion, a P/E ratio of 109.73 and a beta of 1.68. The business has a 50-day moving average of $145.35 and a 200-day moving average of $133.73. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $171.85.

Novanta (NASDAQ:NOVT) last posted its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.03. The company had revenue of $257.71 million during the quarter, compared to analysts’ expectations of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.Novanta’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.74 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. On average, sell-side analysts anticipate that Novanta Inc. will post 3.59 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have issued reports on NOVT shares. Wall Street Zen downgraded Novanta from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Robert W. Baird set a $180.00 price target on Novanta in a report on Tuesday, June 9th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a report on Friday, April 17th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $180.00.

Insider Buying and Selling at Novanta

In other news, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the completion of the transaction, the chief executive officer directly owned 42,761 shares of the company’s stock, valued at $6,432,537.23. This represents a 14.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by corporate insiders.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.